Fund Evaluation Group »

Fibrobiologics shares owned by Fund Evaluation Group

Quarter-by-quarter ownership of Fibrobiologics (FBLG) shares owned by Fund Evaluation Group from 13F filings

Historical chart of Fund Evaluation Group investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Fund Evaluation Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Fund Evaluation Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.3M 1.1M 4.99

More positions owned by Fund Evaluation Group

Ishares Tr Core S&p500 Etf (IVV)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr Us Treas Bd Etf (GOVT)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Msci Eafe Etf (EFA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Schwab Strategic Tr Us Tips Etf (SCHP)
Ishares Tr Short Treas Bd (SHV)
Global X Fds S&p 500 Catholic (CATH)
Ishares Tr Msci Usa Esg Slc (SUSA)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Ishares Tr 10 Yr Invt Gd Corp (IGLB)
Ishares Tr Russell 3000 Etf (IWV)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)

View all positions for Fund Evaluation Group

Top funds holding Fibrobiologics

BlackRock
State Street Corporation
Geode Capital Management
Cascade Financial Partners
Vanguard Group
Requisite Capital Management
American Institute for Advanced Investment Management
Bank of America Corporation
Bank of New York Mellon
Charles Schwab Investment Management
RMR Wealth Builders
Concurrent Investment Advisors
Nuveen Asset Management
ERn Financial
Ethos Financial Group

View all funds holding Fibrobiologics